NO20031390D0 - Aminopyidinyl-, aminoguanidinyl- og alkoksyguanidinylsubstituerte acetamider som proteaseinhibitorer - Google Patents
Aminopyidinyl-, aminoguanidinyl- og alkoksyguanidinylsubstituerte acetamider som proteaseinhibitorerInfo
- Publication number
- NO20031390D0 NO20031390D0 NO20031390A NO20031390A NO20031390D0 NO 20031390 D0 NO20031390 D0 NO 20031390D0 NO 20031390 A NO20031390 A NO 20031390A NO 20031390 A NO20031390 A NO 20031390A NO 20031390 D0 NO20031390 D0 NO 20031390D0
- Authority
- NO
- Norway
- Prior art keywords
- blood
- sup
- compounds
- inhibiting
- formation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23813200P | 2000-10-06 | 2000-10-06 | |
PCT/US2001/031249 WO2002028825A2 (en) | 2000-10-06 | 2001-10-05 | Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20031390D0 true NO20031390D0 (no) | 2003-03-26 |
NO20031390L NO20031390L (no) | 2003-06-03 |
Family
ID=22896640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031390A NO20031390L (no) | 2000-10-06 | 2003-03-26 | Aminopyidinyl-, aminoguanidinyl- og alkoksyguanidinylsubstituerte acetamider som proteaseinhibitorer |
Country Status (26)
Country | Link |
---|---|
US (3) | US6521663B2 (no) |
EP (1) | EP1324981B1 (no) |
JP (1) | JP4256160B2 (no) |
KR (1) | KR20030045103A (no) |
CN (1) | CN1315803C (no) |
AT (1) | ATE337299T1 (no) |
AU (2) | AU1146402A (no) |
BR (1) | BR0114263A (no) |
CA (1) | CA2423883A1 (no) |
CY (1) | CY1106243T1 (no) |
DE (1) | DE60122546T2 (no) |
DK (1) | DK1324981T3 (no) |
ES (1) | ES2269474T3 (no) |
HK (1) | HK1058032A1 (no) |
HR (1) | HRP20030252A2 (no) |
HU (1) | HUP0303149A3 (no) |
IL (1) | IL155160A0 (no) |
MX (1) | MXPA03002998A (no) |
NO (1) | NO20031390L (no) |
NZ (1) | NZ525438A (no) |
PL (1) | PL361185A1 (no) |
PT (1) | PT1324981E (no) |
RU (1) | RU2003113205A (no) |
UA (1) | UA75093C2 (no) |
WO (1) | WO2002028825A2 (no) |
ZA (1) | ZA200303091B (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA75093C2 (en) * | 2000-10-06 | 2006-03-15 | Dimensional Pharm Inc | Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors |
US6610701B2 (en) * | 2001-02-09 | 2003-08-26 | Merck & Co., Inc. | Thrombin inhibitors |
WO2003043624A1 (en) * | 2001-11-16 | 2003-05-30 | Bristol-Myers Squibb Company | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
US7759513B2 (en) * | 2003-02-21 | 2010-07-20 | Nigu Chemie Gmbh | Photolabile protective groups for improved processes to prepare oligonucleotide arrays |
WO2004091613A2 (en) * | 2003-04-10 | 2004-10-28 | 3-Dimensional Pharmaceuticals, Inc. | Substituted phenyl acetamides and their use as protease inhibitors |
US7429603B2 (en) | 2003-04-25 | 2008-09-30 | 3-Dimensional Pharmaceuticals, Inc. | C-fms kinase inhibitors |
US7790724B2 (en) | 2003-04-25 | 2010-09-07 | Janssen Pharmaceutica N.V. | c-fms kinase inhibitors |
US7427683B2 (en) | 2003-04-25 | 2008-09-23 | Ortho-Mcneil Pharmaceutical, Inc. | c-fms kinase inhibitors |
US7914705B2 (en) * | 2005-01-10 | 2011-03-29 | Robert Eliot Sisson | Flowable electrical conductive liquid |
HU0500126D0 (en) * | 2005-01-26 | 2005-04-28 | Sanofi Aventis | New compounds and process for their preparation |
EP1893601A1 (en) * | 2005-06-17 | 2008-03-05 | AstraZeneca AB | Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives |
BRPI0710487A2 (pt) * | 2006-04-12 | 2012-06-05 | Merck & Co Inc | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitácel do mesmo e, método para tratar ou controlar a epilepsia e a dor e para o tratamento ou prevenção de um distúrbio do sono em um paciente. |
RU2354647C2 (ru) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе |
RU2353619C2 (ru) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции |
CN101665465B (zh) * | 2007-09-19 | 2011-09-07 | 复旦大学 | 一种含胍基杂环化合物凝血酶抑制剂及其制备方法 |
BRPI0818244A2 (pt) * | 2007-10-24 | 2015-06-16 | Merck Sharp & Dohme | Composto, composição farmacêutica, uso de um composto, e, método para tratamento de um distúrbio ou doença |
CN103384496B (zh) * | 2010-12-02 | 2016-10-12 | 贝克顿·迪金森公司 | 含有血液稳定剂的血液收集装置 |
CN104857005B (zh) | 2010-12-31 | 2019-04-26 | 阿斯利康公司 | 精氨酸酶抑制剂及其使用方法 |
EP2709446A2 (en) | 2011-05-17 | 2014-03-26 | Velico Medical, Inc. | Platelet storage using a sialidase inhibitor |
US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
WO2014055988A1 (en) | 2012-10-05 | 2014-04-10 | Velico Medical, Inc. | Platelet additive solution having a beta-galactosidase inhibitor |
RU2524647C1 (ru) * | 2012-12-25 | 2014-07-27 | Государственное Бюджетное Учреждение Санкт-Петербургский Научно-Исследовательский Институт Скорой Помощи Им. И.И. Джанелидзе" | Способ лечения синдрома эндогенной интоксикации, обусловленного гиперпротеолизом |
WO2014120886A1 (en) | 2013-01-30 | 2014-08-07 | Velico Medical, Inc. | Platelet additive solution having a self-assembling hydrogel-forming peptide |
WO2015143376A1 (en) * | 2014-03-21 | 2015-09-24 | Nivalis Therapeutics, Inc. | Novel compounds for the treatment of cystic fibrosis |
KR102660070B1 (ko) * | 2015-07-21 | 2024-04-24 | 이뮤노젠 아이엔씨 | 세포독성 벤조다이아제핀 유도체의 제조 방법 |
PL3630742T3 (pl) * | 2017-05-24 | 2024-04-08 | Ramot At Tel-Aviv University Ltd. | Sondy chemiluminescencyjne do obrazowania/wykrywania proteaz |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5084466A (en) | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
CA2075154A1 (en) * | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
DE4208051A1 (de) | 1992-03-13 | 1993-09-16 | Bayer Ag | Substituierte phenylessigsaeureamide |
DE4319887A1 (de) | 1993-06-16 | 1994-12-22 | Hoechst Schering Agrevo Gmbh | Arylacetamide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Fungizide |
DE69432019T2 (de) | 1993-08-12 | 2003-11-27 | Astrazeneca Ab | Amidin-derivate mit stickstoffoxid-synthease-aktivität |
US5885967A (en) | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
JPH0892224A (ja) | 1994-09-16 | 1996-04-09 | Kumiai Chem Ind Co Ltd | 3,5−置換フェニルトリアゾール誘導体および殺虫、殺ダニ剤 |
JP3570752B2 (ja) | 1994-09-22 | 2004-09-29 | 三井化学株式会社 | 4−置換カルボニルクマリン誘導体、およびこれを用いた可視光感光性組成物 |
DE19507822B4 (de) | 1995-02-21 | 2006-07-20 | Schering Ag | Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel |
US5741819A (en) * | 1995-06-07 | 1998-04-21 | 3-Dimensional Pharmaceuticals, Inc. | Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors |
US5721214A (en) | 1995-06-07 | 1998-02-24 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
AU703744B2 (en) * | 1995-06-27 | 1999-04-01 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
DE69625505T2 (de) | 1995-09-29 | 2003-11-13 | Dimensional Pharm Inc | Guanidino proteiase inhibitoren |
DK0892780T3 (da) | 1996-02-22 | 2003-03-03 | Bristol Myers Squibb Pharma Co | m-Amidinophenylanaloger som faktor Xa-inhibitorer |
DE19615262A1 (de) | 1996-04-18 | 1997-10-23 | Bayer Ag | Heteroverknüpfte Phenylglycinolamide |
AU3496297A (en) | 1996-06-25 | 1998-01-14 | Eli Lilly And Company | Anticoagulant agents |
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
DE19642863A1 (de) | 1996-10-17 | 1998-04-23 | Bayer Ag | Amide |
TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
GB9703201D0 (en) | 1997-02-15 | 1997-04-02 | Zeneca Ltd | Chemical compounds |
TR199902012T2 (xx) | 1997-02-21 | 2000-01-21 | Bayer Aktiengesellschaft | Arils�lfonamidler ve analoglar� |
WO1998057929A1 (en) | 1997-06-16 | 1998-12-23 | American Home Products Corporation | Elevation of hdl cholesterol by n-[4-[ (aminothioxomethyl) hydrazono] -4-arylbutyl]amides |
US6034272A (en) | 1997-06-16 | 2000-03-07 | American Home Products Corporation | Elevation of HDL cholesterol by N-[4-[(aminothioxomethyl) hydrazono]-4-arylbutyl]amides |
WO1998057926A1 (en) | 1997-06-16 | 1998-12-23 | American Home Products Corporation | Elevation of hdl cholesterol by n-[2-[ (aminothioxomethyl)hydrazono] -2-arylethyl]amides |
US6049006A (en) | 1997-06-16 | 2000-04-11 | American Home Products Corp. | Elevation of HDL cholesterol by N-[2-[(aminothioxomethyl) hydrazono]-2-arylethyl]amides |
JP2001524467A (ja) * | 1997-11-26 | 2001-12-04 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | ヘテロアリールアミノグアニジンおよびアルコキシグアニジンおよびプロテアーゼインヒビターとしてのこれらの使用 |
CA2260499A1 (en) | 1998-01-29 | 1999-07-29 | Sumitomo Pharmaceuticals Company Limited | Pharmaceutical compositions for the treatment of ischemic brain damage |
US6344486B1 (en) * | 1998-04-03 | 2002-02-05 | 3-Dimensional Pharmaceuticals, Inc. | Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
WO1999055688A1 (en) | 1998-04-27 | 1999-11-04 | Warner-Lambert Company | Substituted diarylalkyl amides as calcium channel antagonists |
DE19824470A1 (de) | 1998-05-30 | 1999-12-02 | Boehringer Ingelheim Pharma | Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE19937494A1 (de) * | 1999-08-07 | 2001-02-08 | Boehringer Ingelheim Pharma | Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel |
US6660885B2 (en) | 2000-03-13 | 2003-12-09 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
UA75093C2 (en) * | 2000-10-06 | 2006-03-15 | Dimensional Pharm Inc | Aminopyridinyl-,aminoguanidinyl-, and alkoxyguanidinesubstituted phenylsubstituted phenylacetamides as protease inhibitors |
-
2001
- 2001-05-10 UA UA2003054058A patent/UA75093C2/uk unknown
- 2001-10-05 AU AU1146402A patent/AU1146402A/xx active Pending
- 2001-10-05 NZ NZ525438A patent/NZ525438A/en unknown
- 2001-10-05 DK DK01979513T patent/DK1324981T3/da active
- 2001-10-05 MX MXPA03002998A patent/MXPA03002998A/es active IP Right Grant
- 2001-10-05 BR BR0114263-1A patent/BR0114263A/pt not_active IP Right Cessation
- 2001-10-05 IL IL15516001A patent/IL155160A0/xx unknown
- 2001-10-05 JP JP2002532411A patent/JP4256160B2/ja not_active Expired - Fee Related
- 2001-10-05 AT AT01979513T patent/ATE337299T1/de not_active IP Right Cessation
- 2001-10-05 PL PL36118501A patent/PL361185A1/xx not_active Application Discontinuation
- 2001-10-05 EP EP01979513A patent/EP1324981B1/en not_active Expired - Lifetime
- 2001-10-05 ZA ZA200303091A patent/ZA200303091B/en unknown
- 2001-10-05 HU HU0303149A patent/HUP0303149A3/hu unknown
- 2001-10-05 CN CNB018182542A patent/CN1315803C/zh not_active Expired - Fee Related
- 2001-10-05 US US09/971,000 patent/US6521663B2/en not_active Expired - Lifetime
- 2001-10-05 KR KR10-2003-7004831A patent/KR20030045103A/ko not_active Application Discontinuation
- 2001-10-05 AU AU2002211464A patent/AU2002211464B2/en not_active Ceased
- 2001-10-05 CA CA002423883A patent/CA2423883A1/en not_active Abandoned
- 2001-10-05 WO PCT/US2001/031249 patent/WO2002028825A2/en active Application Filing
- 2001-10-05 RU RU2003113205/04A patent/RU2003113205A/ru not_active Application Discontinuation
- 2001-10-05 DE DE60122546T patent/DE60122546T2/de not_active Expired - Fee Related
- 2001-10-05 PT PT01979513T patent/PT1324981E/pt unknown
- 2001-10-05 ES ES01979513T patent/ES2269474T3/es not_active Expired - Lifetime
-
2002
- 2002-10-03 US US10/262,871 patent/US6900231B2/en not_active Expired - Lifetime
-
2003
- 2003-03-26 NO NO20031390A patent/NO20031390L/no not_active Application Discontinuation
- 2003-04-03 HR HR20030252A patent/HRP20030252A2/hr not_active Application Discontinuation
-
2004
- 2004-01-02 HK HK0100042A patent/HK1058032A1/xx not_active IP Right Cessation
-
2005
- 2005-01-10 US US11/032,297 patent/US20050159457A1/en not_active Abandoned
-
2006
- 2006-11-14 CY CY20061101657T patent/CY1106243T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031390D0 (no) | Aminopyidinyl-, aminoguanidinyl- og alkoksyguanidinylsubstituerte acetamider som proteaseinhibitorer | |
DK1086122T3 (da) | Pyrazinonproteaseinhibitorer | |
WO1998023565A3 (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors | |
BR9815325A (pt) | Heteroaril, aminoguanidinas e alcóxiguanidinas eseu uso como inibidores da protease | |
ATE270269T1 (de) | Boenzoesäureamid und -sulfonamid substituierte aminoguanidine und alkoxyguanidine als proteaseinhibitoren | |
CA2421548A1 (en) | Amidine inhibitors of serine proteases | |
WO2004091613A3 (en) | Substituted phenyl acetamides and their use as protease inhibitors | |
WO2002006248A3 (en) | Cyclic oxyguanidine pyrazinones as protease inhibitors | |
ATE250056T1 (de) | Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel | |
TR200103491T2 (tr) | Pirazinon trombin inhibitörleri. | |
MXPA03000963A (es) | Inhibidores de oxiguanidina ciclica proteasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |